Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Von Koch Insider Profile
4 Followers
Thomas Von Koch, Ten Percent Owner at Diamedica Therapeutics, holds 4.33M shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, Thomas Von Koch ― shares of Diamedica Therapeutics on ― for an estimated value of ―.
Thomas Von Koch has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Von Koch's holdings
Insider Roles
Ten Percent Owner
Roles that Thomas Von Koch holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Thomas Von Koch
Thomas Von Koch's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Von Koch's performance on stock
You May Also Like
Thomas Von Koch insider profile FAQ
What is the percentage of profitable transactions made by Thomas Von Koch?
The percentage of profitable transactions made by Thomas Von Koch is ―.
What is the average return per transaction made by Thomas Von Koch?
The average return per transaction made by Thomas Von Koch is ―.
What stocks does Thomas Von Koch hold?
Thomas Von Koch holds: DMAC stocks.
What was Thomas Von Koch’s latest transaction?
Thomas Von Koch latest transaction was an Uninformative Buy of ―.
What was Thomas Von Koch's most profitable transaction?
Thomas Von Koch’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Thomas Von Koch's role in Diamedica Therapeutics?
Thomas Von Koch's role in Diamedica Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.